Blood Coagulation Disorder Clinical Trial
— FF8Official title:
The Fear F8ctor Study - Does Fear Induce a Blood Curdling State? The Origin Behind the Phrase Unravelled
For centuries the term "blood curling" has been used to describe extreme frightening
situations. However, the origin of this ancient theory has never been studied and it remains
unknown if fear induces the coagulation system.The objective was to explore the effects of
acute fear on the coagulation system while sitting still. In a crossover study design
healthy subjects will be exposed to a horrifying e.g. scary movie followed by a dull e.g.
flat movie which is shown at least 1 week after the first movie on the same day of the week
at the same time of the day. Participants will be recruited among students from the Leiden
University Medical Center. Blood will be drawn from the cubital vein 10 minutes before the
first movie, directly after the first movie. The same will be done 10 minutes before and
directly after the second movie. Blood is drawn by using a needle puncture.
Individual markers of coagulation activity will be determined from the blood samples. Pulse
rates will be measured and an anxiety/fear score will be collected from each student for
both movies.
Status | Completed |
Enrollment | 24 |
Est. completion date | September 2015 |
Est. primary completion date | August 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 30 Years |
Eligibility |
Inclusion Criteria: - Healthy volunteers between 18 and 30 years old - No medication and otherwise healthy Exclusion Criteria: - Any coagulation disorder - Hormonal anticonception (excluding intrauterine devices) - Pregnancy or puerperium - History of Venous thrombosis - Major surgery or cast immobilisation in the past two months - Neoplasm or inflammatory disease |
Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Leiden University Medical Center |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Factor VIII:C (mean change before and after movie) between movies | The mean change in FVIII:C (in IU/dL) levels after seeing a scary movie (ie from timepoint 0 to 1 in study arm I and from timepoint 2 to timepoint 3 for treatment arm II will be compared to the mean change after seeing a dull movie. A paired student t-test is used to compare the two mean changes in coagulation markers. | Four time points (TP); (0) before the first movie (baseline), after the first movie [90 minutes](1), before the second movie (baseline, 2) and after the second movie [90 minutes](3). All blood will be drawn within 15 minutes before or after the movie. | No |
Primary | Change in D-dimer (mean change before and after movie) between movies | The mean change in D-dimer(in ng/mL) levels after seeing a scary movie (ie from timepoint 0 to 1 in study arm I and from timepoint 2 to timepoint 3 for treatment arm II will be compared to the mean change after seeing a dull movie. A paired student t-test is used to compare the two mean changes in coagulation markers. | Four time points (TP); (0) before the first movie (baseline), after the first movie [90 minutes](1), before the second movie (baseline, 2) and after the second movie [90 minutes](3). All blood will be drawn within 15 minutes before or after the movie. | No |
Primary | Change in Thrombin and Antithrombin complexes (TATc) (mean change before and after movie) between movies | The mean change in TATc (in mcg/L) levels after seeing a scary movie (ie from timepoint 0 to 1 in study arm I and from timepoint 2 to timepoint 3 for treatment arm II will be compared to the mean change after seeing a dull movie. A paired student t-test is used to compare the two mean changes in coagulation markers. | Four time points (TP); (0) before the first movie (baseline), after the first movie [90 minutes](1), before the second movie (baseline, 2) and after the second movie [90 minutes](3). All blood will be drawn within 15 minutes before or after the movie. | No |
Primary | Change in Prothrombin fragments 1+2 (F1+2) (mean change before and after movie) between movies | The mean change in F1+2 (in umol/dL) levels after seeing a scary movie (ie from timepoint 0 to 1 in study arm I and from timepoint 2 to timepoint 3 for treatment arm II will be compared to the mean change after seeing a dull movie. A paired student t-test is used to compare the two mean changes in coagulation markers. | Four time points (TP); (0) before the first movie (baseline), after the first movie [90 minutes](1), before the second movie (baseline, 2) and after the second movie [90 minutes](3). All blood will be drawn within 15 minutes before or after the movie. | No |
Secondary | Difference of Heart Rate (peaks in heart rate) between movies | Heart rates will be measures in beats per minute during the entire movie, using an actiheart device that monitores the heart rate every 15 seconds. | During the entire movie the heart rate is recorded [up to 90 minutes]. Heart rate peaks (above average) will be compared between movies in one individual. | No |
Secondary | Difference of the Visual Analogue Scale on Fear between movies | A VAS (0-10 points) on fear is recorded from every participant after they have seen the dull and scary movie. | VAS scale, directly after dull movie [90 minutes] and directly after scary movie [90 minutes] for each individual | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06174961 -
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
|
Phase 4 | |
Recruiting |
NCT04499274 -
Ondansetron and Blood Coagulation
|
N/A | |
Recruiting |
NCT04507711 -
Palonosetron and Blood Coagulation
|
N/A | |
Recruiting |
NCT06403163 -
Transfusion Surveillance in Anaesthesia
|
||
Terminated |
NCT00288808 -
Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.
|
Phase 1 | |
Completed |
NCT03666650 -
NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers
|
Phase 4 | |
Recruiting |
NCT04896203 -
Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease
|
||
Completed |
NCT03821597 -
Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients
|
N/A | |
Completed |
NCT03168087 -
Plasmalyte-148 Solution and Blood Coagulation
|
||
Not yet recruiting |
NCT05698160 -
Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction
|
||
Completed |
NCT02387944 -
Bedside Evaluation of Coagulation in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT03105180 -
Irrigating Fluid and Blood Coagulation
|
N/A | |
Recruiting |
NCT03255928 -
Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
|
||
Completed |
NCT03280368 -
Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
|
||
Completed |
NCT00493272 -
Dilutional Coagulopathy in Patients Undergoing Elective Surgery
|
Phase 1/Phase 2 | |
Recruiting |
NCT02720679 -
Investigation of the Genetics of Hematologic Diseases
|
||
Completed |
NCT03972839 -
Comparison of Two D-Dimers Dosing Techniques
|
||
Completed |
NCT03734588 -
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
|
Phase 1/Phase 2 | |
Completed |
NCT03876301 -
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
|
||
Completed |
NCT00001927 -
Study of Abnormal Blood Clotting in Children With Stroke
|
N/A |